Addressing the challenges of cleft lip and palate research in India

Peter Mossey; Julian Little

doi:10.4103/0970-0358.57182

Indian Journal of Plastic Surgery, Table of Contents

CC BY-NC-ND 4.0 · Indian J Plast Surg 2009; 42(S 01): S9-S18
DOI: 10.4103/0970-0358.57182

Review Article

Association of Plastic Surgeons of India

Addressing the challenges of cleft lip and palate research in India

Authors

Peter Mossey

Unit of Orthodontics, Dundee University Dental School, 1 Park Place, Dundee, DD1 4HR, Scotland, UK
Julian Little

Unit of Orthodontics, Dundee University Dental School, 1 Park Place, Dundee, DD1 4HR, Scotland, UK

Abstract

PDF Download

ABSTRACT

The Indian sub-continent remains one of the most populous areas of the world with an estimated population of 1.1 billion in India alone. This yields an estimated 24.5 million births per year and the birth prevalence of clefts is somewhere between 27,000 and 33,000 clefts per year. Inequalities exist, both in access to and quality of cleft care with distinct differences in urban versus rural access and over the years the accumulation of unrepaired clefts of the lip and palate make this a significant health care problem in India. In recent years the situation has been significantly improved through the intervention of Non Governmental Organisations such as SmileTrain and Transforming Faces Worldwide participating in primary surgical repair programmes. The cause of clefts is multi factorial with both genetic and environmental input and intensive research efforts have yielded significant advances in recent years facilitated by molecular technologies in the genetic field. India has tremendous potential to contribute by virtue of improving research expertise and a population that has genetic, cultural and socio-economic diversity. In 2008, the World Health Organisation (WHO) has recognised that non-communicable diseases, including birth defects cause significant infant mortality and childhood morbidity and have included cleft lip and palate in their Global Burden of Disease (GBD) initiative. This will fuel the interest of India in birth defects registration and international efforts aimed at improving quality of care and ultimately prevention of non-syndromic clefts of the lip and palate.

KEY WORDS

Epidemiology - Genetics - Treatment - Cleft lip - Cleft palate

PDF (194 kb)

References

REFERENCES
1 Mossey PA, Little J. Chapter 12: Epidemiology of oral clefts: an international perspective. In: Wyszynski DF, editor. Cleft lip and palate. From origin to treatment. Oxford University Press (August 2002) ISBN: 0-19-513906-2. 2002. p. 127-58.
2 WHO Reports, Human Genetics Programme: Management of Noncommunicable Diseases: International Collaborative Research on Craniofacial Anomalies In: Global Strategies Towards Reducing the Health Care Burden of Craniofacial Anomalies In: Mossey PA, Munger R, Murray JC, Shaw WC, editors. Geneva: WHO; 2002 (ISBN 92 4 159038 6).
3 Bearn DR, Mildinhall S, Murphy T. Cleft lip and palate care in the United Kingdom (UK) OE the Clinical Standards Advisory Group (CSAG) Study Part IV OE Outcome comparisons, training and conclusions. Cleft Palate-Craniofac J 2001;38:38-43.
4 Shaw WC, Semb G. Chapter 34: Evidence based care for children with cleft lip and palate. In: Wyszynski DF, editor. Cleft lip and palate. From origin to treatment. Oxford University Press (August 2002) ISBN: 0-19-513906-2. 2002. p. 428-39.
5 Werler M, Lammer EJ, Rosenberg L, Mitchell AA. Maternal cigarette smoking during pregnancy in relation to oral clefts. Am J Epidemiol 1990;132:926-32.
6 Shaw GM, Wasserman CR, Lammer EJ, O'Malley CD, Murray JC, Basart AM, et al. Orofacial clefts, paternal cigarette smoking and transforming growth factor-alpha gene variants. Am J Hum Genet 1996;58:551-61.
7 Kallen K. Maternal smoking and orofacial clefts. Cleft Palate-Craniofac J 1997;34:11-6.
8 Wyszynski DF, Duffy DL, Beaty TH. Maternal cigarette smoking and oral clefts: A meta-analysis. Cleft Palate-Craniofac J 1997;34:206-10.
9 Werler MM, Lammer EJ, Rosenberg L, Mitchell AA. Maternal alcohol use in relation to selected birth defects. Am J Epidemiol 1991;134:691-8.
10 Munger RG, Romitti PA, Daack-Hirsch S, Burns TL, Murray JC, Hanson J. Maternal alcohol use and risk of orofacial cleft birth defects. Teratology 1996;54:27-33.
11 Holmberg PC, Hernberg S, Kurppa K, Rantala K, Riala R. Orofacial clefts and organic solvent exposure during pregnancy. Int Arch Occup Environ Health 1982;50:371-6.
12 Cordier S, Ha MC, Ayme S, Goujard J. Maternal occupational exposure and congenital malformations. Scand J Work Environ Health 1992;18:11-7.
13 Laumon B, Martin JL, Bertucat I, Vernet M, Robert E. Exposure to organic solvents during pregnancy and oral clefts: A case-control study. Reprod Toxicol 1996;10:15-29.
14 Cordier S, Lefeuvre G, Peris-Bonet R, Farinotti M, Lovicu G, Mandereau L, et al. Parental occupation, occupational exposure to solvents and polycyclic aromatic hydrocarbons and risk of childhood brain tumors (Italy, France, Spain). Cancer Causes Control 1997;8:688-97.
15 Gordon JE, Shy CM. Agricultural chemical use and congenital cleft lip and/or palate. Arch Environ Health 1981;36:213-21.
16 Thomas DC, Petitti DB, Goldhaber M, Swan SH, Rappaport EB, Hertz-Picciotto I. Reproductive outcomes in relation to malathion spraying in the San Francisco Bay Area, 1981-1982. Epidemiology 1992;3:32-9.
17 Nurminen T, Rantala K, Kurppa K, Holmberg PC. Agricultural work during pregnancy and selected structural malformations in Finland. Epidemiology 1995;6:23-30.
18 Wyszynski DF, Beaty TH. Review of the role of potential teratogens in the origin of human non syndromic oral clefts. Teratology 1996;53:309-17.
19 Curtis EJ, Fraser FC, Warburton D. Congenital cleft lip and palate. Am J Dis Child 1961;102:853.
20 Tolorova M. Orofacial clefts in Czechoslovakia. Scand J Plast Reconstr Surg 1971;21:19-25.
21 Khoury MJ, Stewart W, Beaty TH. The effect of genetic susceptibility on causal inference in epidemiologic studies. Am J Epidemiol 1987;126:561-7.
22 Wong FK, Hagg U. An update on the aetiology of orofacial clefts. Hong Kong Med J 2004;10:331-6 Review.
23 Tolarova MM, Cervenka J. Classification and birth prevalence of orofacial clefts. Am J Med Genet 1998;75:126-37.
24 Little J, Bryan E. Congenital anomalies in twins. Semin Perinatolol 1986;10:50-64.
25 Christensen K, Fogh-Andersen P. Cleft-twin sets in Finland 1948-1987. Cleft Palate Craniofac J 1996;33:530.
26 Nordstrom RE, Laatikainen T, Juvonen TO, Ranta RE. Cleft-twin sets in Finland 1948-1987. Cleft Palate Craniofac J 1996;33:340-7.
27 Curtis EJ, Fraser FC, Warburton D. Congenital cleft lip and palate. Am J Dis Child 1961;102:853.
28 Carter CO, Evans K, Coffey R, Roberts JA, Buck A, Roberts MF. A three generation family study of cleft lip with or without cleft palate. J Med Genet 1982;19:246-61.
29 Sivertsen A, Wilcox AJ, Skjaerven R, Vindenes HA, Abyholm F, Harville E, et al. Familial risk of oral clefts by morphological type and severity: Population based cohort study of first degree relatives. BMJ 2008;336:432-4.
30 Mossey PA, Little J. Epidemiology of oral clefts: An international perspective. In: Cleft lip and palate: From origins to treatment. In: Wyszynski DF, editor. New York: Oxford University Press; 2002. p. 127-58.
31 Prescott NJ, Lees MM, Winter RM, Malcolm S. Identification of susceptibility loci for nonsyndromic cleft lip with or without cleft palate in a two stage genome scan of affected sib-pairs. Hum Genet 2000;106:345-50.
32 Marazita ML, Field LL, Cooper ME, Tobias R, Maher BS, Peanchitlertkajorn S, et al. Genome scan for loci involved in cleft lip with or without cleft palate, in Chinese multiplex families. Am J Hum Genet 2002;71:349-64.
33 Wyszynski DF, Albacha-Hejazi H, Aldirani M. A genome-wide scan for loci predisposing to nonsyndromic cleft lip with or without cleft palate in two large Syrian families. Am J Med Genet Am 2003;123:140-7.
34 Zeiger JS, Hetmanski JB, Beaty TH, VanderKolk CA, Wyszynski DF, Bailey-Wilson JE, et al. Evidence for linkage of nonsyndromic cleft lip with or without cleft palate to a region on chromosome 2. Eur J Hum Genet 2003;11:835-9.
35 Marazita ML, Murray JC, Lidral AC, Arcos-Burgos M, Cooper ME, Goldstein T, et al. Meta-analysis of 13 genome scans reveals multiple cleft lip/palate genes with novel loci on 9q21 and 2q32-35. Am J Hum Genet 2004;75:161-73.
36 Mitchell LE. Transforming growth factor locus and nonsyndromic cleft lip with or without cleft palate: A reappraisal. Genet Epidemiol 1997;14:231-40.
37 Zeiger JS, Beaty TH, Liang KY. Oral clefts, maternal smoking, and TGFA: A meta-analysis of gene environment interaction. Cleft Palate Craniofac J 2005;42:58-63.
38 Vieira AR. Association between the transforming growth factor alpha gene and nonsyndromic oral clefts: A HuGE review. Am J Epidemiol 2006;163:790-810.
39 Johnson CY, Little J. Folate intake, markers of folate status and oral clefts: Is the evidence converging? Int J Epidemiol 2008;37:1041-58.
40 Verkleij-Hagoort A, Bliek J, Sayed-Tabatabaei F, Ursem N, Steegers E, Steegers-Theunissen R. Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: A meta-analysis. Am J Med Genet A 2007;143:952-60.
41 Chevrier C, Perret C, Bahuau M, Zhu H, Nelva A, Herman C, et al. Fetal and maternal MTHFR C677T genotype, maternal folate intake and the risk of nonsyndromic oral clefts. Am J Med Genet A 2007;143:248-57.
42 Vieira AR, Murray JC, Trembath D, Orioli IM, Castilla EE, Cooper ME, et al. Studies of reduced folate carrier 1 (RFC1) A80G and 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms with neural tube and orofacial cleft defects. Am J Med Genet A 2005;135:220-3.
43 Ioannidis JP, Bernstein J, Boffetta P, Danesh J, Dolan S, Hartge P, et al. A network of investigator networks in human genome epidemiology. Am J Epidemiol 2005;162:302-4.
44 Zucchero TM, Cooper ME, Maher BS, Daack-Hirsch S, Nepomuceno B, Ribeiro L, et al. Interferon regulatory factor 6 (IRF6) is a modifier for isolated cleft lip and palate. N Engl J Med 2004;351:769-80.
45 Ghassibe M, Bayet B, Revencu N, Verellen-Dumoulin C, Gillerot Y, Vanwijck R, et al. Interferon regulatory factor-6: A gene predisposing to isolated cleft lip with or without cleft palate in the Belgian population. Eur J Hum Genet 2005;13:1239-42.
46 Scapoli L, Palmieri A, Martinelli M, Pezzetti F, Carinci P, Tognon M, et al. Strong evidence of linkage disequilibrium between polymorphisms at the IRF6 locus and nonsyndromic cleft lip with or without cleft palate, in an Italian population. Am J Hum Genet 2005;76:180-3.
47 Blanton SH, Cortez A, Stal S, Mulliken JB, Finnell RH, Hecht JT. Variation in IRF6 contributes to nonsyndromic cleft lip and palate. Am J Med Genet A 2005;137:259-62.
48 Srichomthong C, Siriwan P, Shotelersuk V. Significant association between IRF6 820G->A and non-syndromic cleft lip with or without cleft palate in the Thai population. J Med Genet 2005;42:e46.
49 Park JW, McIntosh I, Hetmanski JB, Jabs EW, Vander Kolk CA, Wu-Chou YH, et al. Association between IRF6 and nonsyndromic cleft lip with or without cleft palate in four populations. Genet Med 2007;9:219-27
50 Vieira AR, Cooper ME, Marazita ML, Orioli IM, Castilla EE. Interferon regulatory factor 6 (IRF6) is associated with oral-facial cleft in individuals that originate in South America. Am J Med Genet A 2007;143:2075-8.
51 Jugessur A, Rahimov F, Lie RT, Wilcox AJ, Gjessing HK, Nilsen RM, et al. Genetic variants in IRF6 and the risk of facial clefts: Single-marker and haplotype-based analyses in a population-based case-control study of facial clefts in Norway. Genet Epidemiol 2008;32:413-24.
52 Dode C, Levilliers J, Dupont JM, De Paepe A, Le Dû N, Soussi-Yanicostas N, et al. Loss of function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 2003;33:463-5.
53 Celli J, Duijf P, Hamel BC, Bamshad M, Kramer B, Smits AP, et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 1999;99:143-53.
54 Barrow LL, van Bokhoven H, Daack-Hirsch S, Andersen T, van Beersum SE, Gorlin R, et al. Analysis of the p63 gene in classical EEC syndrome, related syndromes, and non-syndromic orofacial clefts. J Med Genet 2002;39:559-66.
55 Braybrook C, Doudney K, Marcano AC, Arnason A, Bjornsson A, Patton MA, et al. The T-box transcription factor gene TBX22 is mutated in X-linked cleft palate and anykloglossia. Nat Genet 2001;29:179-83.
56 Marcano AC, Doudney K, Braybrook C, Squires R, Patton MA, Lees MM, et al. TBX22 mutations are a frequent cause of cleft palate. J Med Genet 2004;41:68-74.
57 Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kase R, DiGiovanna JJ, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997;69:299-308.
58 Sozen MA, Suzuki K, Tolarova MM, Bustos T, Fernñndez Iglesias JE, Spritz RA. Mutation of PVRL1 is associated with sporadic, non-syndromic cleft lip/palate in northern Venezuela. Nat Genet 2001;29:141-2.
59 Jakobsen LP, Knudsen MA, Lespinasse J, García Ayuso C, Ramos C, Fryns JP, et al. The genetic basis of the Pierre Robin sequence. Cleft Palate Craniofac J 2006;43:155-9.
60 Hwang SJ, Beaty TH, Panny SR, Street NA, Joseph JM, Gordon S, et al. Association study of transforming growth factor alpha (TGFa) TaqI polymorphism and oral clefts: Indication of gene-environment interaction in a population-based sample of infants with birth defects. Am J Epidemiol 1995;141:629-36.
61 Shaw GM, Wasserman CR, Lammer EJ, O'Malley CD, Murray JC, Basart AM, et al. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet 1996;58:551-61.
62 Beaty TH, Maestri NE, Hetmanski JB, Wyszynski DF, Vanderkolk CA, Simpson JC, et al. Testing for interaction between maternal smoking and TGFA genotype among oral cleft cases born in Maryland, 1992-6. Cleft Palate Craniofac J 1997;34:447-54.
63 Christensen K, Olsen J, Nłrgaard-Pedersen B, Basso O, Stłvring H, Milhollin-Johnson L, et al. Oral clefts, transforming growth factor alpha gene variants, and maternal smoking: A population-based case-control study in Denmark, 1991-1994. Am J Epidemiol 1999;149:248-55.
64 Shaw GM, Wasserman CR, Murray JC, Lammer EJ. Infant TGF-alpha genotype, orofacial clefts, and maternal periconceptional multivitamin use. Cleft Palate Craniofac J 1998;35:366-70.
65 Romitti PA, Lidral AC, Munger RG, Daack-Hirsch S, Burns TL, Murray JC. Candidate genes for nonsyndromic cleft lip and palate and maternal cigarette smoking and alcohol consumption: Evaluation of genotype-environment interactions from a population-based case-control study of orofacial clefts. Teratology 1999;59:39-50.
66 Maestri NE, Beaty TH, Hetmanski J, Smith EA, McIntosh I, Wyszynski DF, et al. Application of transmission disequilibrium tests to nonsyndromic oral clefts: Including candidate genes and environmental exposures in the models. Am J Med Genet 1997;73:337-44.
67 Mitchell LE, Murray JC, O'Brien S, Christensen K. Evaluation of two putative susceptibility loci for oral clefts in the Danish population. Am J Epidemiol 2001;153:1007-15.
68 Beaty TH, Hetmanski JB, Zeiger JS, Fan YT, Liang KY, Vanderkolk CA, et al. Testing candidate genes for non-syndromic oral clefts using a case-parent trio design. Genet Epidemiol 2002;22:1-11.
69 Hartsfield JK Jr, Hickman TA, Everett ET, Shaw GM, Lammer EJ, Finnell RA. Analysis of the EPHX1 113 polymorphism and GSTM1 homozygous null polymorphism and oral clefting associated with maternal smoking. Am J Med Genet 2001;102:21-4.
70 van Rooij IA, Wegerif MJ, Roelofs HM, Peters WH, Kuijpers-Jagtman AM, Zielhuis GA, et al. Smoking, genetic polymorphisms in biotransformation enzymes, and nonsyndromic oral clefting: A gene-environment interaction. Epidemiology 2001;12:502-7.
71 van Rooij IA, Groenen PM, van Drongelen M, Te Morsche RH, Peters WH, Steegers-Theunissen RP. Orofacial clefts and spina bifida: N-acetyltransferase phenotype, maternal smoking, and medication use. Teratology 2002;66:260-6.
72 Lammer EJ, Shaw GM, Iovannisci DM, Finnell RH. Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts. Birth Defects Res A Clin Mol Teratol 2004;70:846-52.
73 Shaw GM, Nelson V, Iovannisci DM, Finnell RH, Lammer EJ. Maternal occupational chemical exposures and biotransformation genotypes as risk factors for selected congenital anomalies. Am J Epidemiol 2003;157:475-84.
74 Mitchell LE, Murray JC, O'Brien S, Christensen K. Retinoic acid receptor alpha gene variants, multivitamin use, and liver intake as risk factors for oral clefts: A population-based case-control study in Denmark, 1991-1994. Am J Epidemiol 2003;158:69-76.
75 van Rooij IA, Vermeij-Keers C, Kluijtmans LA, Ocké MC, Zielhuis GA, Goorhuis-Brouwer SM, et al. Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymorphisms affect the risk of cleft lip with or without cleft palate? Am J Epidemiol 2003;157:583-91.
76 Little J, Gilmour M, Mossey PA, FitzPatrick D, Cardy A, Clayton-Smith J, et al. Folate and clefts of the lip and palate: A UK based case-control study: Part I: Dietary and supplemental folate. Cleft Palate Craniofacial J 2008;45:420-27.
77 Shaw GM, Todoroff K, Finnell RH, Rozen R, Lammer EJ. Maternal vitamin use, infant C677T mutation in MTHFR, and isolated cleft palate risk. Am J Med Genet 1999;85:84-5.
78 Martinelli M, Scapoli L, Pezzetti F, Carinci F, Carinci P, Stabellini G, et al. C677T variant form at the MTHFR gene and CL/P: A risk factor for mothers? Am J Med Genet 2001;98:357-60.
79 Jugessur A, Wilcox AJ, Lie RT, Murray JC, Taylor JA, Ulvik A, et al. Exploring the effects of methylenetetrahydrofolate reductase gene variants C677T and A1298C on the risk of orofacial clefts in 261 Norwegian case-parent triads. Am J Epidemiol 2003;157:1083-91.
80 Shaw GM, Zhu H, Lammer EJ, Yang W, Finnell RH. Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects. Am J Epidemiol 2003;158:747-52.
81 Chevrier C, Perret C, Bahuau M, Zhu H, Nelva A, Herman C, et al. Fetal and maternal MTHFR C677T genotype, maternal folate intake and the risk of nonsyndromic oral clefts. Am J Med Genet A 2007;143:248-57.
82 Fryer AA, Jones PW. Interactions between detoxifying enzyme polymorphisms and susceptibility to cancer. IARC Sci Publ 1999;148:303-22.
83 Davey Smith G, Ebrahim S. What can Mendellian Randomisation tell us about Modifiable, Behavioural and Environmental Exposures? BMJ 2005;330:1076-9.
84 IIIPS National Family and Health Survey, India, 1992-93. Mumbai: International Institute for Population Sciences; 1995.
85 Sastri KA. A history of South India: From prehistoric times to the fall of Vijayanagar. 4th ed. Madras: Oxford University Press; 1976. p. 66.